Category: MS Drug Therapies

Fourth PML Case With Tecfidera in MS Calls for Vigilance

Sue Hughes December 17, 2015 After a fourth case of progressive multifocal leukoencephalopathy (PML) linked to the multiple sclerosis (MS) drug dimethyl…

Stuart Schlossman

Alkermes enrolling MS patients to assess safety of ALKS 8700 (MMF) compared to Tecfidera

New MS Drug Therapy Based on Monomethyl Fumarate  Moving Along in Testing Dec 18, 2015 Alkermes plc, a biopharmaceutical company…

Stuart Schlossman

New MS Drug Shows ‘Excellent Profile’ in Preclinical Tests Against Approved Therapy

Akaal Pharma, a developer of small molecule drugs for the treatment of inflammation and autoimmune diseases including multiple sclerosis (MS),…

Stuart Schlossman

New Zealand MS update: Multiple sclerosis drugs to receive funding

By Martin Johnston Tuesday Dec 8, 2015 Tecfidera capsules and Aubagio tablets will be state-funded from February 1. Photo / iStock…

Stuart Schlossman

Learn more about 3-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg

Learn more about 3-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Watch doctors share their experiences Watch Dr. Stuart Fox and…

Stuart Schlossman

A multiple sclerosis drug that works for Huntington’s disease: the real deal or too good to be true?

Fingolimod, a drug used in multiple sclerosis, prevents memory problems in HD mice. Would it work in patients? By Melissa Christianson on…

Stuart Schlossman

Multiple Sclerosis Drug Does Not Cause Cancer

Researchers from the Queen Mary University of London are calling on healthcare professionals to reinitiate development of a multiple sclerosis…

Stuart Schlossman

Takeda introduces multiple sclerosis drug Copaxone subcutaneous injection 20 mg syringe in Japan

Osaka, JapanFriday, November 27, 2015, 12:00 Hrs  [IST] Takeda Pharmaceutical Company Limited, a research-based global company, announced that the multiple sclerosis…

Stuart Schlossman

Empowering Columbia, South Carolina’s MS Community with MS information

Dr. Walker’s presentation begins at approximately 7 minutes into this video. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ MS Views and News helps to provide information…

Stuart Schlossman

Treatment adherence in multiple sclerosis: a survey of Belgian neurologists

Authors Decoo D, Vokaer M Received 8 July 2015 Accepted for publication 25 September 2015 Published 19 November 2015 Volume…

Stuart Schlossman

Categories

Latest Blog Posts